about
Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxisUsing value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.Principles for consistent value assessment and sustainable funding of orphan drugs in Europe.Costs and utilization of treatment in patients with hemophilia.Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL).Tertiary prophylaxis in adults: is there a rationale?Emerging drugs for the treatment of hemophilia A and B.Improving haemophilia patient care through sharing best practice.Haemophilia care in Europe - a survey of 35 countries.Assessing options for treating haemophilia with inhibitors.Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatment.Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia.
P2860
Q26865814-D96A5396-DE0E-4326-A93A-A386B9AE73EAQ34011908-CF07EEA3-F2E1-4FAC-8641-0057A0C5CD93Q35610429-4E251B56-9D37-45E7-99B2-302ECB66BA31Q35821757-6C0B7845-E10F-46B9-802E-E7B1A1F88A87Q37692633-CA774B24-32B2-43F7-8FEC-BE9DA634CBE9Q38013763-D8F2C07C-96F1-4824-BDEC-901E340254A0Q38933707-01E6E2F9-569D-4DBF-BC47-39C2092E3CC4Q42643647-3F4D5A67-F8A1-4816-8025-FBAE85F64BC0Q44041201-57AB971D-C843-447F-A639-B5E887801A5BQ45874793-D4224F83-D439-4640-BCE2-9F4DEB870C74Q45886106-49E09F66-DEFB-4013-8E0A-BEE963C30B55Q45886531-CAE03796-9407-47A3-B309-B7551A7427EF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Health technology assessment and haemophilia.
@en
Health technology assessment and haemophilia.
@nl
type
label
Health technology assessment and haemophilia.
@en
Health technology assessment and haemophilia.
@nl
prefLabel
Health technology assessment and haemophilia.
@en
Health technology assessment and haemophilia.
@nl
P2860
P1433
P1476
Health technology assessment and haemophilia.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2516.2012.02754.X
P577
2012-03-01T00:00:00Z